Last reviewed · How we verify
subretinal injection of rAAV.hPDE6A — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
subretinal injection of rAAV.hPDE6A (subretinal injection of rAAV.hPDE6A) — STZ eyetrial.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| subretinal injection of rAAV.hPDE6A TARGET | subretinal injection of rAAV.hPDE6A | STZ eyetrial | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- subretinal injection of rAAV.hPDE6A CI watch — RSS
- subretinal injection of rAAV.hPDE6A CI watch — Atom
- subretinal injection of rAAV.hPDE6A CI watch — JSON
- subretinal injection of rAAV.hPDE6A alone — RSS
Cite this brief
Drug Landscape (2026). subretinal injection of rAAV.hPDE6A — Competitive Intelligence Brief. https://druglandscape.com/ci/subretinal-injection-of-raav-hpde6a. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab